Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost

201513 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Contemporary Clinical Trials

Volume 44, pp. 112-118

Field-Weighted Citation Impact: 1.30